Company
Protagonist Therapeutics Inc PTGX
Tracked across 3 disclosed holders on Protégé.
Held by these investors
| Investor | % of portfolio | Value |
|---|---|---|
| Farallon Capital Management | 4.6% | $778.2M |
| Stanley Druckenmiller | 0.6% | $25.6M |
| Woodline Partners | 0.5% | $173.3M |
Company
Tracked across 3 disclosed holders on Protégé.
| Investor | % of portfolio | Value |
|---|---|---|
| Farallon Capital Management | 4.6% | $778.2M |
| Stanley Druckenmiller | 0.6% | $25.6M |
| Woodline Partners | 0.5% | $173.3M |